Now showing 1 - 10 of 39
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Scopus© Citations 4
  • Some of the metrics are blocked by your 
    Item type:Publication,
    External validation and comparison of six cardiovascular risk prediction models in the Prospective Urban Rural Epidemiology (PURE)-Colombia study
    (Oxford University Press (OUP), 2025-06-07)
    Lopez-atalaya Jose P.
    ;
    Ángel A. Garcia-Peña
    ;
    Martinez-bello Daniel
    ;
    Gonzalez Ana M.
    ;
    Maritza Perez-Mayorga
    AbstractTo externally validate the SCORE2, AHA/ACC pooled cohort equation (PCE), Framingham Risk Score (FRS), Non-Laboratory INTERHEART Risk Score (NL-IHRS), Globorisk-LAC, and WHO prediction models and compare their discrimination and calibration capacity. Methods and results Validation in individuals aged 40–69 years with at least 10 years of follow-up and without baseline use of statins or cardiovascular diseases from the Prospective Urban Rural Epidemiology (PURE)-Colombia prospective cohort study. For discrimination, the C-statistic, and receiver operating characteristic curves with the integrated area under the curve (AUCi) were used and compared. For calibration, the smoothed time-to-event method was used, choosing a recalibration factor based on the integrated calibration index (ICI). In the NL-IHRS, linear regressions were used. In 3802 participants (59.1% women), baseline risk ranged from 4.8% (SCORE2 women) to 55.7% (NL-IHRS). After a mean follow-up of 13.2 years, 234 events were reported (4.8 cases per 1000 person-years). The C-statistic ranged between 0.637 (0.601–0.672) in NL-IHRS and 0.767 (0.657–0.877) in AHA/ACC PCE. Discrimination was similar between AUCi. In women, higher over-prediction was observed in the Globorisk-LAC (61%) and WHO (59%). In men, higher over-prediction was observed in FRS (72%) and AHA/ACC PCE (71%). Overestimations were corrected after multiplying by a factor derived from the ICI. Conclusion Six prediction models had a similar discrimination capacity, supporting their use after multiplying by a correction factor. If blood tests are unavailable, NL-IHRS is a reasonable option. Our results suggest that these models could be used in other countries of Latin America after correcting the overestimations with a multiplying factor.
    Scopus© Citations 20
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Scopus© Citations 75
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk: An International Expert Consultation
    (Elsevier BV, 2017-07)
    Alberto Morales Salinas
    ;
    Antonio Coca
    ;
    Michael H. Olsen
    ;
    Ramiro A. Sanchez
    ;
    Weimar K. Sebba-Barroso
    Scopus© Citations 21
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Editorial: Global excellence in cardiovascular medicine: Central and South America
    (Frontiers Media SA, 2024-06-17)
    In the last decades Central and South America have experienced rapid changes in lifestyle resulting in a higher burden of cardiometabolic risk factors and a greater contribution of non-communicable diseases to mortality and morbidity. Recently, the results of a large prospective study conducted in South America showed that over two-thirds of deaths in the region were due to either cardiovascular disease (CVD), cancer, or respiratory diseases. Only modest differences in the incidence of CVD were observed between countries . In all countries, men experienced higher rates of CVD and death compared with women. Deaths were also consistently higher in rural areas across all countries. Incident CVD was largely attributable to 12 modifiable risk factors, with metabolic risk factors being the most prevalent. The largest population-attributable fractions (PAF) for CVD were hypertension, smoking, and abdominal obesity. Outdoor air pollution, an important risk factor for CVD, was not included.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 Countries
    (Ovid Technologies (Wolters Kluwer Health), 2021-06)
    Isabelle Johansson
    ;
    Philip Joseph
    ;
    Kumar Balasubramanian
    ;
    John J.V. McMurray
    ;
    Lars H. Lund
    <jats:sec> <jats:title>Background:</jats:title> <jats:p>Poor health-related quality of life (HRQL) is common in heart failure (HF), but there are few data on HRQL in HF and the association between HRQL and mortality outside Western countries.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods:</jats:title> <jats:p>We used the Kansas City Cardiomyopathy Questionnaire–12 (KCCQ-12) to record HRQL in 23 291 patients with HF from 40 countries in 8 different world regions in the G-CHF study (Global Congestive Heart Failure). We compared standardized KCCQ-12 summary scores (adjusted for age, sex, and markers of HF severity) among regions (scores range from 0 to 100, with higher score indicating better HRQL). We used multivariable Cox regression with adjustment for 15 variables to assess the association between KCCQ-12 summary scores and the composite of all-cause death, HF hospitalization, and each component over a median follow-up of 1.6 years.</jats:p> </jats:sec> <jats:sec> <jats:title>Results:</jats:title> <jats:p> The mean age of participants was 65 years; 61% were men; 40% had New York Heart Association class III or IV symptoms; and 46% had left ventricular ejection fraction ≥40%. Average HRQL differed between regions (lowest in Africa [mean± SE, 39.5±0.3], highest in Western Europe [62.5±0.4]). There were 4460 (19%) deaths, 3885 (17%) HF hospitalizations, and 6949 (30%) instances of either event. Lower KCCQ-12 summary score was associated with higher risk of all outcomes; the adjusted hazard ratio (HR) for each 10-unit KCCQ-12 summary score decrement was 1.18 (95% CI, 1.17–1.20) for death. Although this association was observed in all regions, it was less marked in South Asia, South America, and Africa (weakest association in South Asia: HR, 1.08 [95% CI, 1.03–1.14]; strongest association in Eastern Europe: HR, 1.31 [95% CI, 1.21–1.42]; interaction <jats:italic>P</jats:italic> &lt;0.0001). Lower HRQL predicted death in patients with New York Heart Association class I or II and III or IV symptoms (HR, 1.17 [95% CI, 1.14–1.19] and HR, 1.14 [95% CI, 1.12–1.17]; interaction <jats:italic>P</jats:italic> =0.13) and was a stronger predictor for the composite outcome in New York Heart Association class I or II versus class III or IV (HR 1.15 [95% CI, 1.13–1.17] versus 1.09 [95% CI, [1.07–1.11]; interaction <jats:italic>P</jats:italic> &lt;0.0001). HR for death was greater in ejection fraction ≥40 versus &lt;40% (HR, 1.23 [95% CI, 1.20–1.26] and HR, 1.15 [95% CI, 1.13–1.17]; interaction <jats:italic>P</jats:italic> &lt;0.0001). </jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion:</jats:title> <jats:p>HRQL is a strong and independent predictor of all-cause death and HF hospitalization across all geographic regions, in mildly and severe symptomatic HF, and among patients with preserved and reduced ejection fraction.</jats:p> </jats:sec> <jats:sec> <jats:title>Registration:</jats:title> <jats:p> URL: <jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.clinicaltrials.gov">https://www.clinicaltrials.gov</jats:ext-link> ; Unique identifier: NCT03078166. </jats:p> </jats:sec>
    Scopus© Citations 281
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Control y tratamiento de la hipertensión arterial: Programa 20-20
    (Publicidad Permanyer, SLU, 2019-03)
    Juan Felipe Gómez
    ;
    Paul Anthony Camacho
    ;
    José López-López
    ;
    Scopus© Citations 15
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Scopus© Citations 1
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Diet and Clinical Outcomes in a Heart Failure Population
    (Elsevier BV, 2026-04)
    Joseph, Philip
    ;
    Dehghan, Mahshid
    ;
    Ezekowitz, Justin A.
    ;
    Miller, Victoria
    ;
    Lanas, Fernando
    Scopus© Citations 3
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Carbonated Beverage, Fruit Drink, and Water Consumption and Risk of Acute Stroke: the INTERSTROKE Case-Control Study
    (Korean Stroke Society, 2024-09-30)
    Andrew Smyth
    ;
    Graeme J. Hankey
    ;
    Albertino Damasceno
    ;
    Helle Klingenberg Iversen
    ;
    Shahram Oveisgharan
    Background and Purpose Cold beverage intake (carbonated drinks, fruit juice/drinks, and water) may be important population-level exposures relevant to stroke risk and prevention. We sought to explore the association between intake of these beverages and stroke.Methods INTERSTROKE is an international matched case-control study of first stroke. Participants reported beverage intake using food frequency questionnaires or were asked “How many cups do you drink each day of water?” Multivariable conditional logistic regression estimated odds ratios (OR) and 95% confidence intervals (CI) for associations with stroke.Results We include 13,462 cases and 13,488 controls; mean age was 61.7±13.4 years and 59.6% (n=16,010) were male. After multivariable adjustment, carbonated beverages were linearly associated with ischemic stroke (OR 2.39 [95% CI 1.64–3.49]); only consumption once/day was associated with intracerebral hemorrhage (ICH) (OR 1.58 [95% CI 1.23–2.03]). There was no association between fruit juice/drinks and ischemic stroke, but increased odds of ICH for once/day (OR 1.37 [95% CI 1.08–1.75)] or twice/day (OR 3.18 [95% CI 1.69–5.97]). High water intake (&gt;7 cups/day) was associated ischemic stroke (OR 0.82 [95% CI 0.68–0.99]) but not ICH. Associations differed by Eugeographical region—increased odds for carbonated beverages in some regions only; opposing directions of association of fruit juices/drinks with stroke in selected regions. Conclusion Carbonated beverages were associated with increased odds of ischemic stroke and ICH, fruit juice/drinks were associated with increased odds of ICH, and high water consumption was associated with reduced odds of ischemic stroke, with important regional differences. Our findings suggest optimizing water intake, minimizing fruit juice/drinks, and avoiding carbonated beverages.
    Scopus© Citations 6